Trials / Conditions / Multicentric Castleman Disease
Multicentric Castleman Disease
4 registered clinical trials studyying Multicentric Castleman Disease — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers NCT05663502 | AIDS Malignancy Consortium | — |
| Active Not Recruiting | Safety and Efficacy of Rituximab for Treatment of Multicentric Castleman Disease in Malawi NCT04585893 | UNC Lineberger Comprehensive Cancer Center | Phase 2 |
| Unknown | TCP Regimen in Newly Diagnosed MCD:a Prospective, Single-center, Single-arm, Phase-II Pilot Trial NCT03043105 | Peking Union Medical College Hospital | Phase 2 |
| Completed | Tocilizumab for KSHV-Associated Multicentric Castleman Disease NCT01441063 | National Cancer Institute (NCI) | Phase 2 |